Use

The Fetal Hemoglobin Determination test is designed to detect and quantify the extent of fetomaternal hemorrhage in pregnant or postpartum women. This is critical for assessing the need for Rh immunoglobulin (e.g., RhoGAM) in cases of suspected fetomaternal hemorrhage, which can occur during pregnancy or after childbirth. By determining the percentage of fetal red blood cells (RBCs) in the maternal circulation using flow cytometry, healthcare providers can accurately calculate the necessary dosage of RhIG and intervene appropriately to prevent hemolytic disease and other complications that may arise from fetal-maternal blood mixing.